NANOBIOTIX (EPA:NANO) | Finanzwire

Basculer en Français

9475	Companies
185452	Keywords
117801	Articles
99309	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 08/27/2025 at 08:00, 3 months 9 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix announces voting rights and shares capital details as per French Commercial Code regulations. The late-stage clinical biotech company focuses on disruptive therapies in oncology, bioavailability, and CNS disorders

Voting Rights French Commercial Code Biotechnology Shares Capital NANOBIOTIX
BRIEF

published on 08/11/2025 at 11:34, 3 months 25 days ago

Threshold Crossings by The Goldman Sachs Group, Inc. at Nanobiotix

Actions Financial Market Goldman Sachs Crossing Thresholds NANOBIOTIX
BRIEF

published on 07/07/2025 at 22:20, 4 months 28 days ago

NANOBIOTIX: Reclassification and New Patent for JNJ-1900 (NBTXR3)

Patent NANOBIOTIX Regulatory JNJ-1900 Harmonization
PRESS RELEASE

published on 07/07/2025 at 22:15, 4 months 28 days ago

NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)
Nanobiotix announces regulatory harmonization and new composition of matter patent filed for JNJ-1900 (NBTXR3), aiming to reinforce global positioning of potential first-in-class radioenhancer

NANOBIOTIX JNJ-1900 Global Positioning Regulatory Harmonization Composition Of Matter Patent
BRIEF

published on 06/24/2025 at 12:39, 5 months 11 days ago

Goldman Sachs Crosses Stake Threshold in Nanobiotix

Stock Market Acquisition Of Shares Goldman Sachs Threshold Crossing NANOBIOTIX
BRIEF

published on 06/10/2025 at 22:20, 5 months 24 days ago

Number of Shares and Voting Rights of Nanobiotix

Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/10/2025 at 22:15, 5 months 24 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses voting rights and shares capital. The company is a biotechnology pioneer with disruptive therapeutic approaches. Visit www.nanobiotix.com for more info

Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
BRIEF

published on 05/21/2025 at 22:20, 6 months 14 days ago

Nanobiotix Reports Q1 2025 Achievements and Financial Status

Biotechnology Financial Update NANOBIOTIX JNJ-1900 Cancer Trials
PRESS RELEASE

published on 05/21/2025 at 22:15, 6 months 14 days ago

Nanobiotix Provides First Quarter 2025 Operational and Financial Update
Nanobiotix provides operational and financial update for Q1 2025, including CONVERGE study dosing, financial strengthening, and €39.8M cash reserves as of March 31, 2025

Operational Update Financial Update Cash Reserves NANOBIOTIX CONVERGE Study
BRIEF

published on 04/14/2025 at 22:20, 7 months 20 days ago

Nanobiotix: Monthly update of voting rights and shares

Share Capital Voting Rights Euronext Nasdaq NANOBIOTIX

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 58 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 11 hours 3 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 12 hours 33 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 28 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 33 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:00, 33 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 33 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 28 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 33 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 33 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million

Les Echos

Published on 12/05/2025 at 08:45, 4 hours 48 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 33 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 48 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 49 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE